03:34 AM EDT, 08/05/2024 (MT Newswires) -- Yvonne Greenstreet, Director, Chief Executive Officer, on August 01, 2024, sold 15,148 shares in Alnylam Pharmaceuticals ( ALNY ) for $4,089,960. Following the Form 4 filing with the SEC, Greenstreet has control over a total of 73,848 shares of the company, with 73,441 shares held directly and 407 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1178670/000173527624000077/xslF345X03/edgardoc.xml

Price: 270.00, Change: -2.05, Percent Change: -0.75